Therapeutic Use Exemptions : the World Anti-Doping Code International Standard / World Anti-Doping Agency (WADA). - Montreal : WADA, 2014. - (International Standard for Therapeutic Use Exemptions (ISTUE) effective on 1 January 2015)
The International Standard for Therapeutic Use Exemptions was first adopted in 2004 and came into effect 1 January 2005. Further revisions were made in 2009, 2010 and 2011. The enclosed ISTUE incorporates revisions to the ISTUE and was approved at the World Conference on Doping in Sport in Johannesburg by the WADA Executive Committee on 15 November 2013. It will come into effect on 1 January 2015.
The International Standard for Therapeutic Use Exemptions is a mandatory International Standard developed as part of the World Anti-Doping Program.
The purpose of the International Standard for Therapeutic Use Exemptions is to establish
(a) the conditions that must be satisfied in order for a Therapeutic Use Exemption (or TUE) to be granted, permitting the presence of a Prohibited Substance in an Athlete’s Sample or the Athlete’s Use or Attempted Use, Possession and/or Administration or Attempted Administration of a Prohibited Substance or Prohibited Method for therapeutic reasons;
(b) the responsibilities imposed on Anti-Doping Organizations in making and communicating TUE decisions;
(c) the process for an Athlete to apply for a TUE;
(d) the process for an Athlete to get a TUE granted by one Anti-Doping Organization recognized by
another Anti-Doping Organization; (e) the process for WADA to review TUE decisions; and (f) the strict confidentiality provisions that apply to the TUE process.